Endoscopy 2012; 44(12): 1158-1160
DOI: 10.1055/s-0032-1325795
Case report
© Georg Thieme Verlag KG Stuttgart · New York

Use of paclitaxel-eluting balloons for endotherapy of anastomotic strictures following liver transplantation

I. Kabar
1   Department of Transplant Medicine, University Hospital Münster, Münster, Germany
,
V. R. Cicinnati
1   Department of Transplant Medicine, University Hospital Münster, Münster, Germany
,
S. Beckebaum
1   Department of Transplant Medicine, University Hospital Münster, Münster, Germany
,
S. Cordesmeyer
1   Department of Transplant Medicine, University Hospital Münster, Münster, Germany
,
Y. Avsar
1   Department of Transplant Medicine, University Hospital Münster, Münster, Germany
,
H. Reinecke
2   Division of Angiology, Department of Cardiology and Angiology, University Hospital Münster, Münster, Germany
,
H. H. Schmidt
1   Department of Transplant Medicine, University Hospital Münster, Münster, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
27 November 2012 (online)

Preview

Biliary anastomotic strictures after liver transplantation are a major source of morbidity and graft failure; however, repeated endoscopic therapy has shown variable long-term success rates. Thus the aim of this prospective case series was to evaluate the safety and efficacy of using paclitaxel-eluting balloons in 13 patients requiring treatment for symptomatic anastomotic strictures following liver transplantation. Sustained clinical success—defined as no need for further endoscopic intervention for at least 6 months – was achieved in 12 /13 patients (92 %). One, two, and three interventions were required in 9 (69 %), 1, and 2 patients, respectively (mean number of sessions was 1.46). Mean (± SD) bilirubin level dropped from 6.8 (± 4.1) mg/dL to 1.4 (± 0.9) mg/dL. These promising results justify carrying out a randomized comparative trial to confirm this innovative approach.